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Abstract 
Vitamin D is a fundamentally critical nutrient that the human body requires to function properly. It plays an 
important role in musculoskeletal health due to its involvement in the regulation of calcium and 
phosphorus. Having a low level of vitamin D in the body may be detrimental for a wide range of health 
outcomes, including risk of osteoporotic and stress fractures, risk of CVD and some cancers, and 
lowering of the capability of the immune system. Vitamin D is an unusual nutrient; it is not a vitamin, in 
the true sense of the word but a pro-hormone. The main source of vitamin D is UV exposure, not dietary 
intake. Interestingly, there are two forms of vitamin D, vitamin D2 and vitamin D3, both of which are 
metabolised into 25-hydroxyvitamin D (25(OH)D) in the liver, the biomarker of vitamin D status. Vitamin D 
deficiency is a global public health problem, especially amongst older people and ethnic minority groups. 
The newest publication from the UK Government's Public Health England Department recommends that 
vitamin D intake should be 10 μg daily and this recommendation compares well (albeit lower) with other 
guidelines such as the Institute of Medicine recommendation of 15 μg for those aged 1–70 years and 20 
μg for those 70 years or over. Few countries, however, have a specific vitamin D policy to prevent 
deficiency in populations. Finland leads the way, demonstrating impressive results in reducing population-
level vitamin D deficiency through mandatory food fortification programmes. Collaboration between 
academia, government and industry, including countries from varying latitudes, is essential to identify 
long-term solutions to the global issue of vitamin D deficiency. This paper provides a narrative review of 
the evidence related to the role of vitamin D deficiency in health outcomes, outlines controversies 
regarding setting levels of adequacy, identifies the prevalence of vitamin D deficiency across the globe, 
and identifies population-level strategies adopted by countries to prevent vitamin D deficiency. 
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Vitamin D is a fundamentally critical nutrient that the human body requires to function
properly. It plays an important role in musculoskeletal health due to its involvement in the
regulation of calcium and phosphorus. Having a low level of vitamin D in the body may
be detrimental for a wide range of health outcomes, including risk of osteoporotic and stress
fractures, risk of CVD and some cancers, and lowering of the capability of the immune
system. Vitamin D is an unusual nutrient; it is not a vitamin, in the true sense of the word
but a pro-hormone. The main source of vitamin D is UV exposure, not dietary intake.
Interestingly, there are two forms of vitamin D, vitamin D2 and vitamin D3, both of
which are metabolised into 25-hydroxyvitamin D (25(OH)D) in the liver, the biomarker of
vitamin D status. Vitamin D deficiency is a global public health problem, especially amongst
older people and ethnic minority groups. The newest publication from the UK Government’s
Public Health England Department recommends that vitamin D intake should be 10 μg daily
and this recommendation compares well (albeit lower) with other guidelines such as the
Institute of Medicine recommendation of 15 μg for those aged 1–70 years and 20 μg for
those 70 years or over. Few countries, however, have a specific vitamin D policy to prevent
deficiency in populations. Finland leads the way, demonstrating impressive results in reducing
population-level vitamin D deficiency through mandatory food fortification programmes.
Collaboration between academia, government and industry, including countries from varying
latitudes, is essential to identify long-term solutions to the global issue of vitamin D defic-
iency. This paper provides a narrative review of the evidence related to the role of vitamin
D deficiency in health outcomes, outlines controversies regarding setting levels of adequacy,
identifies the prevalence of vitamin D deficiency across the globe, and identifies population-
level strategies adopted by countries to prevent vitamin D deficiency.
Vitamin D: Deficiency: Global: Future perspectives
Vitamin D is essential for musculoskeletal health,
particularly due to its involvement in the regulation of
calcium and phosphorus(1,2). Vitamin D is a unique
nutrient in that it is not a vitamin, in the true sense of
the word, but actually a pro-hormone, with its main
source being an exposure of skin to UV rays (at 290–
315 nm), not dietary intake(2). Over the past two decades,
there has been mounting scientific and clinical evidence
that vitamin D deficiency, defined as 25-hydroxyvitamin
D (25(OH)D) concentrations below 25 nmol/l, and
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inadequacy, defined as 25(OH)D concentrations below
50 nmol/l, are a major public health issue across all age
groups and populations, but especially amongst older
people and ethnic minority groups (a group of people
who identify with each other, either on the basis of a pre-
sumed common genealogy or ancestry or on similarities
such as common language, history, society, culture or
nation)(3–7).
The two main forms of vitamin D are naturally pre-
sent in a few foods and in small quantities, with ergocal-
ciferol (vitamin D2) from plant and/or fungal sources,
such as mushrooms and cholecalciferol (D3) from animal
origin foods such as oily fish, butter, eggs and liver. It is
important to appreciate that the vitamin D content in
these food sources can vary dramatically between coun-
tries due to environmental and agricultural factors and
that usual dietary intake of vitamin D-rich foods varies
widely between populations(2). For instance, the vitamin
D content of milk is known to be subjected to seasonal
variations, presenting, as expected, higher content in
summer months in comparison to wintertime. Several
studies have indeed demonstrated a variation in vitamin
D concentration in milk, ranging from 0⋅004 to 0⋅0014
μg/g fat, across not only different breeds of cattle, but
also different locations(8).
Habitual exposure of the skin to UVB radiation in
sunlight (wavelength between 290 and 315 nm) converts
the molecule 7-dehydrocholesterol, naturally present in
the epidermis, into pre-vitamin D3
( 2,9). Pre-vitamin D3
is thermodynamically unstable and is thus quickly meta-
bolised to vitamin D3 through thermal isomerisation.
Vitamin D3 then binds to vitamin-D-binding protein in
the bloodstream and is transported to the liver, along
with vitamin D absorbed from dietary sources (food
and supplements)(2). In the liver, these molecules undergo
a first hydroxylation by the cytochrome P450 enzyme
CYP2R1 (25-hydroxylase) to produce the major circulat-
ing form, 25(OH)D(2). The molecule 25(OH)D under-
goes further hydroxylation in the kidneys, by enzyme
CYP27B1 (1α-hydroxylase), resulting in the active form
of vitamin D (1α,25(OH)2D3), which is the main bio-
logical active metabolite(2).
Atmospheric conditions, such as cloud, ozone and
humidity can cause absorption or deflection of much of
the UV rays in sunlight before it reaches the earth’s sur-
face(10,11). Since ozone absorbs UVB radiation, holes in
the ozone layer caused by pollution could potentially
enhance vitamin D levels of populations due to an
increase of UVB radiation passing through these holes.
Conversely, air pollution will disperse and absorb UVB
radiation, reducing the availability of UVB rays reaching
the ground, and consequently reducing the production of
vitamin D in the skin.
In the UK, the latest data from the rolling National
Diet and Nutrition Survey 2008/2009–2011/2012 pro-
vides evidence of an increased risk of vitamin D defic-
iency in all age/sex groups(12). Year-round, 7⋅5 % of
children aged 1⋅5–3 years and 24⋅4% of children aged
11–18 years had serum 25(OH)D concentrations below
25 nmol/l(12). In adults, 16⋅9% of men and 24⋅1% of
women, aged 65 years and over, had serum 25(OH)D
concentration below 25 nmol/l, with the prevalence
being higher in the wintertime(12). The recent Scientific
Advisory Committee on Nutrition report published in
2016, suggests that the mean intake of vitamin D (from
all sources, including supplements) for the general
British population is 2–4 μg/d for ages 1⋅5–64 years and
5 μg/d for adults aged 65 years or over(13).
Why is vitamin D so important?
The biologically active vitaminDmetabolite 1α,25(OH)2D3
is involved in bone formation as well as bone matur-
ation(1,2). Along with parathyroid hormone, it regulates
calcium and phosphorus metabolism and enhances the
absorption of calcium in the gut and reabsorption of
filtered calcium in the kidney(1,2). Vitamin D is, therefore,
essential to help maintain muscle function and an opti-
mal status may help reduce the risk of falls and fractures,
particularly in older people. Prolonged and severe vita-
min D deficiency may lead to rickets in children and
osteomalacia/osteoporosis in adults(1,2).
Although data is still largely observational, recent evi-
dence also suggests that Vitamin D may have an import-
ant role in the pathophysiology of conditions as diverse
as inflammatory and heart diseases, type I and II dia-
betes, various types of cancer and multiple scler-
osis(3,14,15). However, while the essential role of vitamin
D in the maintenance of calcium homeostasis ad skeletal
health is well recognised, there is still a substantial lack of
robust evidence, with few well-designed randomised con-
trolled trials (RCT) to elucidate the effect of vitamin D
deficiency in other non-skeletal related health outcomes.
The costs associated with vitamin D deficiency in the
population are staggering, with a recent National
Health Service report estimating that approximately 10
million people in England alone may have low vitamin
D status, with treatment costs for vitamin D deficiency
calculated to be over £70 million per year for
England(16).
Controversy: where to set the cut-point for total 25(OH)
D status?
Defining vitamin D deficiency
The most common criteria used for determining the opti-
mal serum 25(OH)D concentration for bone health in
adults are the levels that result in (1) suppression of para-
thyroid hormone secretion; (2) greater bone mineral
density; (3) lower rates of bone loss; and (4) decreased
incidence of fractures and falls(17,18). There is still much
debate and controversy about which levels of circulating
25(OH)D should be considered to define states of defic-
iency, insufficiency and sufficiency, and consequently
lack of consensus on a definition for optimal vitamin
D status. There is, though, general agreement that circu-
lating 25(OH)D concentrations of populations should
not decrease below 25 nmol/l in order to preserve bone
health(18,19).





















The UK Scientific Advisory Committee on Nutrition
classifies vitamin D deficiency as 25(OH)D concentra-
tions below 25 nmol/l(13), the Institute of Medicine in
the US defines insufficiency as 25(OH)D concentrations
below 50 nmol/l(19) and the US Endocrine Society pro-
poses 75 nmol/l(20) as the minimum level required to pre-
vent detrimental effects to health.
Vitamin D recommendations
Previously in the UK, a reference nutrient intake for vita-
min D was set only for population groups deemed to be
at high risk of deficiency, assuming that for most people
the amount of vitamin D synthesised in the skin by
exposure to sunlight was sufficient to reach serum
25(OH)D concentrations ≥25 nmol/l throughout the
year(13). However, increasing new evidence proved this
not to be the case and the new publication from the
UK Government’s Public Health England Department
recommends a vitamin D daily intake of 10 μg for the
UK population aged 4 years and over, including indivi-
duals from minority ethnic groups with darker skin(13).
The Institute of Medicine and the Endocrine Society in
the US recommendations are much higher than the
UK reference standards, namely an RDA of 15 μg of
vitamin D for individuals aged 1–70 years, increasing
to 20 μg for those older than 70 years(19,20).
Vitamin D status worldwide
Over the past three decades, the increasing prevalence of
inadequate vitamin D status has been reported in differ-
ent populations worldwide(3,5,21–23). The majority of the
data comes from studies and national surveys in high lati-
tude countries, which is not surprising due to the known
challenges of maintaining adequate vitamin D levels in
these locations, especially during winter.
A systematic review conducted in 2013, of studies pub-
lished in the previous 10 years in apparently healthy indi-
viduals, reported a remarkably high prevalence of low
vitamin D status (in places with available data) in all
age groups, but especially in girls and women from the
Middle East(24). More recently, emerging evidence indi-
cates that low vitamin D concentrations are alarmingly
common, also in low latitude countries, despite the abun-
dance of sunlight(25–27).
In the UK, data from the rolling National Diet and
Nutrition Survey programme of 977 individuals showed
a mean 25(OH)D level of 44⋅8 nmol/l in adults aged
19 years or over (Fig. 1). A recent study applying
Vitamin D Standardization Program protocols to four-
teen studies, combined with four previously standardised
studies, from representative European populations,
estimated that 40 and 13% of 55 844 individuals had
average year-round 25(OH)D concentrations below 50
and 30 nmol/l, respectively. Remarkably, dark-skinned
ethnic groups were estimated to have a substantially
higher prevalence of levels below 30 nM, ranging from
3- up to 71-fold, compared to white individuals(23).
A multinational study conducted in 2004/2005 that
included eighteen countries ranging in latitude from 64°
N to 38°S, with 2606 participants, observed that low
25(OH)D concentrations were common among postme-
nopausal women with osteoporosis, with 64% of this
sample having levels below 75 nmol/l. Mean 25(OH)D
concentration was 67 (SE 0⋅75) nmol/l and values ranged
from 15 to 607 nmol/l, with regional mean concentra-
tions lowest in the Middle East (51 nmol/l, SE 1⋅25) and
highest in Latin America (74 nmol/l, SE 1⋅5)(4).
In the US, data from the National Health and
Nutrition Examination Survey population reported a
mean 25(OH)D concentration of 65 nmol/l in individuals
aged 20–59 years and 62⋅5 nmol/l within those 60 years
or over (Fig. 1). The number of individuals with 25
(OH)D concentrations below 75 nmol/l almost doubled
from 1994 to 2004, reaching a figure of nearly 75 % of
the American population by 2004. Within dark-skinned
populations (Black, Hispanic and Asians), the prevalence
of levels below 75 nmol/l was more than 90% in this
cohort(28).
A longitudinal cohort study in South Australia (lati-
tude 34°S) with 2413 participants, conducted between
2008 and 2010 (Stage 3 of the Nutrition, Water,
Sanitation and Hygiene Study), observed an overall
mean serum 25(OH)D of 69⋅2 nmol/l with 22⋅7% of the
population having concentrations below 50 nmol/l
(Fig. 1)(29). Another study in Australia in 126 healthy
free-living adults (aged 18–87 years) reported a preva-
lence of 10⋅2 and 32⋅3 % of individuals with serum
25(OH)D concentrations below 25 and 50 nmol/l,
respectively, at the end of winter(30). Studies conducted
in several different cities in Brazil found a high preva-
lence of 25(OH)D concentrations below 50 nmol/l, with
values as high as 57⋅3% in the city of São Paulo (latitude
23°S) (Fig. 1), 31⋅5% in Recife (latitude 8°S), 63⋅7% in
Curitiba (latitude 25°S), with the latter study being con-
ducted in adolescents(25,31,32).
Strategies for improving vitamin D status in the
population
Vitamin D supplementation and/or food fortification
have been increasingly discussed worldwide as an effect-
ive strategy to tackle low vitamin D levels, particularly
since natural food sources are limited in most countries.
Vitamin D supplementation has been gaining popularity
over recent years, in line with widespread claims of the
preventive or therapeutic effects of vitamin D being
related to a diverse range of health outcomes. Over the
past 15 years, research has been dedicated to determining
the best ways of improving vitamin D status of popula-
tions, either through the supplemental intake and/or
food fortification, and have debated whether vitamin
D2 or D3 should be the preferred source.
It was previously believed that there were no differ-
ences between vitamin D2 (ergocalciferol) and vitamin
D3 (cholecalciferol) in their effectiveness in improving
vitamin D concentrations(33). However, a recent rando-
mised, double-blind, placebo-controlled food-fortification





















trial, conducted in 335 healthy South Asian and
Caucasian European women (20–64 years) living in
Southern England, has demonstrated that vitamin D3
was more effective than vitamin D2 in increasing serum
25(OH)D in the wintertime. This suggests that vitamin
D3 might be the better option to optimise vitamin D sta-
tus within the general population(33). In the trial, study
participants received either a placebo, juice supplemen-
ted with 15 μg vitamin D2, biscuit supplemented with
15 μg vitamin D2, juice supplemented with 15 μg vitamin
D3, or biscuit supplemented with 15 μg vitamin D3 daily
for 12 weeks. Serum 25(OH)D was measured by liquid
chromatography–tandem MS at baseline and at weeks
6 and 12 of the study. The findings from this relevant
study suggested that both juice and biscuits are viable
products for fortification strategies to effectively raise
25(OH)D concentrations.
Regarding strategies to reduce vitamin D deficiency at
a population level through mandatory food fortification
programmes, Finland has taken the lead by implement-
ing a systematic national fortification programme and
has shown this to be an effective approach. A voluntary
food fortification policy was introduced in Finland in
2003 advising food manufacturers to add 10 μg/100 g
vitamin D to fat spreads and 0⋅5 μg/100 g to milk pro-
ducts. National reports showed that over a period of 10
years, mean 25(OH)D concentrations increased from
47⋅6 to 65⋅4 nmol/l in adults(34). Furthermore, the preva-
lence of 25(OH)D concentrations below 30 nmol/l
decreased from 13 to 0⋅6 %. It is worth noting that during
the same survey period, reported supplement use also
increased, from 11 to 41 %(34).
In this sense, another key recent project on vitamin D
is the European Commission-funded ODIN project
(food-based solutions for optimal vitamin D nutrition
and health throughout the life cycle), a cross-disciplinary,
collaborative project, including thirty partners from nine-
teen countries. This project aimed to develop evidence-
based solutions to prevent low vitamin D status
(25(OH)D) <30 nmol/l) using a food-first approach(35).
The ODIN project is the first internationally standar-
dised dataset of vitamin D status and included almost
56 000 EU residents(35). A summary overview published
in 2018, reported that across a latitude of regions ranging
from 35 to 69°N, 13 and 40 % had serum 25(OH)D
below 30 and 50 nmol/l, respectively, with the risk of
low vitamin D status higher among ethnic minorities(35).
Within the ODIN project, four dose-response RCT were
conducted in Northern Europe, accompanied by a series
of food production studies, food-based RCT and dietary
modelling experiments. The study collaborators con-
cluded that diverse fortification strategies could safely
increase population intakes and prevent low vitamin D
status(35).
A review discussing the impact of urban living high
latitude, urban living and ethnicity on 25(OH)D status,
published in 2019, proposes a further discussion on the
key role of a multidisciplinary approach on tackling vita-
min D deficiency globally(36). This multidisciplinary
approach would bring together and apply knowledge
from dietitians, nutritionists, endocrinologists, psycholo-
gists, social scientists, photobiologists, biochemists, engi-
neers, town planners etc. This is crucial to be able to
consider all the aspects involved in vitamin D status of
populations, with particular relevance for ethnic minority
groups(36).
Vitamin D supplementation RCT have consistently
demonstrated the dependence of the response to vitamin
D supplements on initial vitamin D concentrations,
although this factor has not been considered in most
studies conducted in the past(37,38). This is an important
point to be considered when discussing the benefits of
vitamin D supplements, as it might explain the various
negative results from vitamin D supplementation studies
that have investigated its effect on the incidence and risk
of falls and/or fractures. For instance, a recent review
Fig. 1. Mean 25(OH)D (nmol/l) by country.





















that investigated the proportion of RCT that studied
vitamin D deficient populations found that 70 % of
RCT included participants with baseline 25(OH)D over
40 nmol/l and of the twenty-five large RCT (completed
or ongoing), only one investigated a vitamin D deficient
population, while three focused on vitamin D insufficient
populations. Individuals that are vitamin D sufficient are
considered unlikely to benefit from supplementation and
could even potentially mask the beneficial effect to those
with deficient or insufficient levels(39).
Conclusions
This narrative review has demonstrated that vitamin
D inadequacy is a global public health issue and that
whilst populations at higher latitudes are at greater risk
of deficiency, particularly during winter, the concern is
now extended to a global level. Targeting intervention
strategies specific to each population, country and the
ambient setting is important if benefits are to be
optimised. Studies specifically designed to investigate
the effect of, and requirements for, vitamin D supple-
ments in each country or ethnic group are urgently
required to contribute to an improved definition of
vitamin D deficiency and more specific and efficient
recommendations.
Recommendations for either supplementation or food
fortification need to consider the availability of each vita-
min D source (dietary intake, either from food or supple-
ments, and endogenous production from sunlight
exposure), individual characteristics and lifestyle aspects.
Moreover, there are key considerations to be taken into
account for the proposal of supplementation and fortifi-
cation programmes. Firstly, identification of the opti-
mum level of blood concentrations for optimal vitamin
D status and recommended daily intake remains contro-
versial, both of which are the bases for determining sup-
plementation or fortification strategies, particularly for
programmes implemented at population levels.
Moreover, such programmes will also need to be tailored
to incorporate culturally and geographically appropriate
choices of vehicles for fortification, consider the bioavail-
ability of the fortificant and consider current intake levels
for each country and/or ethnic group targeted.
Inter-individual variability in vitamin D status could
be reasonably explained by differences in the metabolism
of vitamin D. The VDR gene plays an important role in
Vitamin D metabolism and polymorphisms in this gene
can potentially affect Vitamin D gene expression, mean-
ing that genetic variation could explain the considerable
differences in vitamin D levels among population inde-
pendently of latitude and sunlight exposure(40).
Moreover, some research suggests that some polymorph-
isms in GC and CYP2R1 genes (involved in vitamin
D metabolism) are associated with 25(OH)D concentra-
tions(40,41). Therefore further research, with robust data
from clinical trials, investigating genetic factors influen-
cing vitamin D concentrations could be key in better
understanding how to tackle vitamin D deficiency in dif-
ferent populations.
In the near future, climate changes are expected to affect
food production and the interactions between environ-
ment, agricultural systems and livestock will have a critical
impact on future diets and health outcomes. However, the
extent and pathways, and potential consequences, are still
mainly unclear. Future research will need to consider an
approach with an interdisciplinary tactic, linking multiple
interactions between environmental changes, agricultural
productivity and livestock systems, with a specific focus
on vitamin D availability through both food intake and
photochemical production in the skin.
Additional research is still required to understand inter-
individual variability in the metabolism of vitamin D and
differences in response to supplementation, which may be
due to genetic polymorphisms. Environmental, cultural
and individual factors that influence vitamin D status,
including during supplementation, need to be better eluci-
dated. Such factors include adiposity, season, cultural and
clothing habits, skin pigmentation, sun exposure and diet-
ary habits also required further investigation to determine
what extent each factor affects vitamin D status.
Regarding supplementation strategies, particular issues
include accessibility to vitamin D supplements and com-
pliance/reluctance with supplement intake.
Most importantly, there is an urgent need for studies
that appropriately investigate the response to supplemen-
tation or fortification considering initial concentrations of
25(OH)D to interpret the effect of changes between base-
line and post-supplementation on the studied outcomes.
Collaborative efforts between academia, government
and industry, including countries from several different
latitudes, are required to implement effective long-term
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